Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Changes in plasma beta 2 microglobulin concentrations after allogeneic bone marrow transplantation.

D R Norfolk, M A Forbes, E H Cooper

    Journal of Clinical Pathology
    |June 1, 1987
    PubMed
    Summary

    Serial measurements of beta 2 microglobulin (B2M) in bone marrow transplant patients can help monitor chronic graft-versus-host disease. This biomarker, while non-specific, shows potential clinical utility in BMT patient management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database.

    Pediatric surgery international·2023
    Same author

    DNA Genotypic Conservation During Phenotypic Switch from T-cell Acute Lymphoblastic Leukaemia to Acute Myeloblastic Leukaemia.

    Leukemia & lymphoma·2016
    Same author

    Novel Haematological Parameters in Patients Receiving Recombinant Human Erythropoietin and Undergoing Haemodialysis.

    Hematology (Amsterdam, Netherlands)·2016
    Same author

    A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.

    Leukemia·2011
    Same author

    Current uses of transfusion administration sets: a cause for concern?

    Transfusion medicine (Oxford, England)·2010
    Same author

    When and why is blood crossmatched? A prospective survey of transfusion laboratory practice in two regions in the north of England.

    Vox sanguinis·2010

    Area of Science:

    • Immunology
    • Transplantation Medicine
    • Biomarker Discovery

    Background:

    • Beta 2 microglobulin (B2M) is the light chain of the class I major histocompatibility complex.
    • Allogeneic bone marrow transplantation (BMT) is a complex procedure with potential complications.
    • Monitoring patient recovery and complications post-BMT is crucial for successful outcomes.

    Purpose of the Study:

    • To investigate the serial plasma concentrations of B2M in patients undergoing allogeneic BMT.
    • To assess the correlation of B2M levels with transplant conditioning, engraftment, infections, and graft-versus-host disease (GVHD).
    • To determine the clinical utility of serial B2M measurements in BMT patient management.

    Main Methods:

    • Serial measurement of plasma beta 2 microglobulin (B2M) concentrations.

    Related Experiment Videos

  • Patient cohort included 26 individuals undergoing allogeneic bone marrow transplantation (BMT).
  • B2M levels were analyzed in relation to conditioning treatment, engraftment, bacterial infections, viral infections (HSV, VZV, CMV), and acute and chronic GVHD.

    • Main Results:

    • Plasma B2M concentrations decreased post-conditioning and increased upon marrow engraftment.
    • Bacterial infections did not significantly affect B2M levels.
    • Raised B2M concentrations were associated with acute GVHD (9/22 episodes) and chronic GVHD (8/8 episodes), with levels decreasing after treatment.
    • Viral infections, including cytomegalovirus (CMV) pneumonitis, were also linked to elevated B2M, with increases preceding symptom onset in CMV pneumonitis cases.

    Conclusions:

    • Serial plasma B2M measurements are non-specific but clinically useful in monitoring chronic graft-versus-host disease in BMT patients.
    • B2M monitoring may aid in the early detection and management of GVHD post-transplantation.
    • Further research could explore B2M's role in predicting or managing other BMT-related complications.